Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies

Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies Publisher Pubmed

Moghadasi AN¹ ; Pourmand S¹ ; Sharifian M¹ ; Minagar A² ; Sahraian MA¹

Show Affiliations

1. MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Sina Hospital Hassan Abad Square, Tehran, 1136746911, Iran
2. Department of Neurology, Louisiana State University Health Sciences Center - Shreveport, 1501 Kings Highway, Shreveport, 71130, LA, United States

Source: Neurologic Clinics Published:2016

Abstract

Multiple sclerosis (MS) is the most common nontraumatic cause of physical disability in young adults. Cognitive and neuropsychiatric problems are common in this disease independent of motor disability. Such problems especially in mild cases are ignored by physicians, although they may have a major impact on quality of life. Neurobehavioral changes may affect the adherence to treatment and worsen the ultimate prognosis. Although many studies have been performed in this regard, it seems that combining cognitive evaluations with other outcome measures in MS will enhance the understanding of neurobehavioral changes in MS. © 2016 Elsevier Inc.

Related Docs

View other Related Docs

1. Personality Characteristics in Ms Patients: The Role of Avoidant Personality, Clinical Neurology and Neurosurgery (2016)

2. Primary Progressive Multiple Sclerosis in Iran: A Consensus Recommendation for Diagnosis and Management, Multiple Sclerosis and Related Disorders (2018)

3. Demographic Features, Behavioral Measures, and Clinical Factors As Predictors of Cognitive Function in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2021)

4. Efficacy and Tolerability of Phytomedicines in Multiple Sclerosis Patients: A Review, CNS Drugs (2017)

5. Immune-Mediated Cognition Impairment in Multiple Sclerosis, Translational Neuroimmunology: Multiple Sclerosis: Volume 8 (2023)

6. Perspectives of Medieval Persian Medicine on Multiple Sclerosis, Current Drug Metabolism (2018)

7. Fear of Relapse, Social Support, and Psychological Well-Being (Depression, Anxiety, and Stress Level) of Patients With Multiple Sclerosis (Ms) During the Covid-19 Pandemic Stage, Neurological Sciences (2021)

8. The Effect of Atomoxetine on Cognitive Function in Patients With Multiple Sclerosis, Current Journal of Neurology (2023)

Experts (# of related papers)

View all Related Experts

Mohammad Ali Sahraian (4)

Amirreza Azimi (1)

Style	Citing Format
MLA	Moghadasi AN, et al.. "Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies." Neurologic Clinics, vol. 34, no. 1, 2016, pp. 17-31.
APA	Moghadasi AN, Pourmand S, Sharifian M, Minagar A, Sahraian MA (2016). Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies. Neurologic Clinics, 34(1), 17-31.
Chicago	Moghadasi AN, Pourmand S, Sharifian M, Minagar A, Sahraian MA. "Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies." Neurologic Clinics 34, no. 1 (2016): 17-31.
Harvard	Moghadasi AN et al. (2016) 'Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies', Neurologic Clinics, 34(1), pp. 17-31.
Vancouver	Moghadasi AN, Pourmand S, Sharifian M, Minagar A, Sahraian MA. Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies. Neurologic Clinics. 2016;34(1):17-31.
BibTex	@article{ author = {Moghadasi AN and Pourmand S and Sharifian M and Minagar A and Sahraian MA}, title = {Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies}, journal = {Neurologic Clinics}, volume = {34}, number = {1}, pages = {17-31}, year = {2016} }
RIS	TY - JOUR AU - Moghadasi AN AU - Pourmand S AU - Sharifian M AU - Minagar A AU - Sahraian MA TI - Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies JO - Neurologic Clinics VL - 34 IS - 1 SP - 17 EP - 31 PY - 2016 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract